June 9, 2016
June 9, 2016 —
The University of California San Diego School of Medicine has launched the Institute for Diabetes and Metabolic Health (IDMH), a new cross-disciplinary, collaborative effort to address one of the nation’s leading public health threats.
June 6, 2016
June 6, 2016 —
Pancreatic ductal adenocarcinoma, the most common of pancreatic cancers, is extraordinarily lethal, with a 5-year survival rate of just 6 percent. In a new study, researchers at University of California San Diego School of Medicine and Moores Cancer Center, together with colleagues at Keio University, the University of Nebraska and Ionis Pharmaceuticals describe an innovative new model that not only allowed them to track drug resistance in vivo, but also revealed a new therapeutic target.
May 23, 2016
May 23, 2016 —
In a paper published in the current Journal of Alzheimer’s Disease, researchers at University of California San Diego School of Medicine and Veterans Affairs San Diego Healthcare System say existing screening tools for mild cognitive impairment (MCI) result in a false-negative error rate of more than 7 percent. These persons are misclassified as not having MCI based on standard screening instruments but actually do have MCI when more extensive testing is conducted.
May 20, 2016
May 20, 2016 —
All scientific achievement begins with an idea. Yesterday, three researchers at University of California San Diego School of Medicine were awarded funding by the Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) to pursue budding ideas that might eventually impact the field of human stem cell research.
May 19, 2016
May 19, 2016 —
Immunology – and the idea that many diseases can best be addressed by boosting the body’s own immune response – is one of the hottest areas in medical research and clinical treatment. University of California San Diego School of Medicine and Chiba University School of Medicine in Japan have announced a new collaborative research center to investigate the most promising aspects of immunology, especially the area of mucosal immunology, and to speed development of clinical applications.
May 12, 2016
May 12, 2016 —
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers at University of California San Diego School of Medicine, after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed by Merck & Co. under the name Januvia.
May 11, 2016
May 11, 2016 —
Family planning is a major health issue in India, the world’s second most populous country. Researchers at University of California San Diego School of Medicine describe a novel program that involves increased male engagement and gender-equity counseling to measurably improve contraceptive practices and reduced marital sexual violence.
May 11, 2016
May 11, 2016 —
Researchers at University of California San Diego School of Medicine, with colleagues in Brazil and Senegal, have described the first “direct experimental proof” that the Brazilian strain of Zika virus can actually cause severe birth defects. The findings are published in the May 11 online issue of Nature.
May 11, 2016
May 11, 2016 —
In a massive analysis of DNA samples from more than 13,000 U.S. soldiers, scientists have identified two statistically significant genetic variants that may be associated with an increased risk of post-traumatic stress disorder (PTSD), an often serious mental illness linked to earlier exposure to a traumatic event, such as combat and an act of violence.
April 26, 2016
April 26, 2016 —
The California HIV/AIDS Research Program (CHRP) of University of California has awarded grants totaling $9.4 million to three teams of investigators to provide and evaluate PrEP – the HIV prevention pill – among transgender persons at risk for HIV acquisition in California.
